{"doi":"10.1016/0165-0327(88)90075-4","title":"Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial","abstract":null,"journal":"Journal of Affective Disorders","year":1988,"id":34563,"datarank":18.699446213879487,"base_score":5.6240175061873385,"endowment":5.6240175061873385,"self_citation_contribution":0.8436026259281009,"citation_network_contribution":17.855843587951387,"self_endowment_contribution":0.8436026259281009,"citer_contribution":17.855843587951387,"corpus_percentile":null,"corpus_rank":null,"citation_count":276,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":178823,"name":"J.A. Hollyman","orcid":null,"position":1,"is_corresponding":false},{"id":178824,"name":"P. Freeling","orcid":null,"position":2,"is_corresponding":false},{"id":116692,"name":"P. Sedgwick","orcid":null,"position":3,"is_corresponding":false},{"id":178822,"name":"E.S. Paykel","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":5.6240175061873385,"endowment":5.6240175061873385,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"2963054","pmcid":null,"openalex_id":"https://openalex.org/W2095847653","authors":[],"funders":[],"total_grants":0,"fwci":9.0428,"citation_percentile":0.98619376,"influential_citations":4,"citation_trend":[{"year":2012,"count":4},{"year":2013,"count":3},{"year":2014,"count":3},{"year":2015,"count":4},{"year":2017,"count":1},{"year":2018,"count":3},{"year":2020,"count":3},{"year":2022,"count":1},{"year":2023,"count":1},{"year":2024,"count":1}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:0165032788900754?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:0165032788900754?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/0165-0327(88)90075-4","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/2963054","host_type":"repository"}],"fields_of_study":["Treatment of Major Depression","Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","Bipolar Disorder and Treatment","Psychology","Medicine"],"mesh_terms":["Adolescent","Adult","Amitriptyline","Clinical Trials as Topic","Depressive Disorder","Double-Blind Method","Humans","Middle Aged","Prognosis","Psychological Tests"],"keywords":["Amitriptyline","Placebo","Depression (economics)","Tricyclic","Hamilton depression scale","Endogenous depression","Placebo response","Melancholia","Psychology","Tricyclic antidepressant","Psychiatry","Antidepressant","Medicine","Internal medicine","Anesthesia","Pharmacology","Mood","Anxiety","Hamd"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-09T19:03:53.273332Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}